Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

493 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Alteration of the Gut-Lung Axis After Severe COVID-19 Infection and Modulation Through Probiotics: A Randomized, Controlled Pilot Study.
Horvath A, Habisch H, Prietl B, Pfeifer V, Balazs I, Kovacs G, Foris V, John N, Kleinschek D, Feldbacher N, Grønbæk H, Møller HJ, Žukauskaitė K, Madl T, Stadlbauer V. Horvath A, et al. Among authors: john n. Nutrients. 2024 Nov 8;16(22):3840. doi: 10.3390/nu16223840. Nutrients. 2024. PMID: 39599626 Free PMC article. Clinical Trial.
Prognostic Relevance of Tricuspid Annular Plane Systolic Excursion to Systolic Pulmonary Arterial Pressure Ratio and Its Association With Exercise Hemodynamics in Patients With Normal or Mildly Elevated Resting Pulmonary Arterial Pressure.
John T, Avian A, John N, Eger A, Foris V, Zeder K, Olschewski H, Richter M, Tello K, Kovacs G, Douschan P. John T, et al. Among authors: john n. Chest. 2024 Sep 26:S0012-3692(24)05269-3. doi: 10.1016/j.chest.2024.09.013. Online ahead of print. Chest. 2024. PMID: 39341493
Longitudinal analysis of PD-L1 expression in patients with relapsed NSCLC.
John N, Schlintl V, Sassmann T, Lindenmann J, Fediuk M, Wurm R, Douschan P, Zacharias M, Kalson L, Posch F, Absenger G, Brcic L, Jost PJ, Terbuch A. John N, et al. J Immunother Cancer. 2024 Apr 11;12(4):e008592. doi: 10.1136/jitc-2023-008592. J Immunother Cancer. 2024. PMID: 38604811 Free PMC article.
Early kinetics of C reactive protein for cancer-agnostic prediction of therapy response and mortality in patients treated with immune checkpoint inhibitors: a multicenter cohort study.
Barth DA, Moik F, Steinlechner S, Posch F, Mayer MC, Sandner AM, Berton F, Schlintl V, Koch L, John N, Wurm R, Pichler M, Bauernhofer T, Reimann P, Wohlkönig C, Richtig E, Winder T, Preusser M, Jost PJ, Ay C, Gerger A, Terbuch A, Riedl JM. Barth DA, et al. Among authors: john n. J Immunother Cancer. 2023 Dec 14;11(12):e007765. doi: 10.1136/jitc-2023-007765. J Immunother Cancer. 2023. PMID: 38097343 Free PMC article.
Prognostic impact of targetable driver alterations in resected early-stage lung cancer.
Terbuch A, Konjic S, Schlintl V, Absenger G, Jost PJ, Lindenmann J, Swatek P, John N, John T, Wurm R, Zacharias M, Posch F, Hochmair MJ, Fabikan H, Weinlinger C, Illini O, Horvath L, Gamerith G, Wolf D, Augustin F, Brcic L. Terbuch A, et al. Among authors: john t, john n. Transl Lung Cancer Res. 2024 Nov 30;13(11):3096-3105. doi: 10.21037/tlcr-24-433. Epub 2024 Nov 14. Transl Lung Cancer Res. 2024. PMID: 39670019 Free PMC article.
Early Change in C-Reactive Protein and Venous Thromboembolism in Patients Treated With Immune Checkpoint Inhibitors.
Moik F, Riedl JM, Barth D, Berton F, Fink M, Englisch C, Hoeller C, Fuereder T, Ay L, Pabinger I, Richtig E, John N, Kostmann SM, Jost PJ, Gerger A, Terbuch A, Preusser M, Ay C. Moik F, et al. Among authors: john n. JACC CardioOncol. 2024 Nov 12;6(6):965-975. doi: 10.1016/j.jaccao.2024.09.007. eCollection 2024 Dec. JACC CardioOncol. 2024. PMID: 39801631 Free PMC article.
Crossing the streams: Improving data quality and integration across the One Health genomics continuum with data standards and implementation strategies.
Griffiths E, Jurga E, Wajnberg G, Shay JA, Cameron R, Barclay C, Sehar A, Dooley D, John NS, Scott A, Johnson LA, Robertson J, Schonfeld J, Bastedo DP, Tang J, Yin X, Rehman A, Wallace RL, Thomas K, Eagle SHC, McAllister TA PhD, Diarra M, Nash J, Topp E, Van Domselaar G, Taboada E, Tamber S, Kess T, Broadbent J, Poulin-Laprade D, Smith DDN, Reid-Smith R, Zaheer R, Laing CR, Carrillo CD, Hsiao W. Griffiths E, et al. Among authors: john ns. Can J Microbiol. 2025 Jan 20. doi: 10.1139/cjm-2024-0203. Online ahead of print. Can J Microbiol. 2025. PMID: 39832351
PD-L1-Expression in in primary and recurrent vulvar squamous cell cancer.
Stuebs FA, Knöll A, Hartmann A, Leikauf LS, Matek C, John N, Häberle L, Beckmann MW, Geppert CI. Stuebs FA, et al. Among authors: john n. Gynecol Oncol. 2025 Jan 10;193:98-104. doi: 10.1016/j.ygyno.2025.01.001. Online ahead of print. Gynecol Oncol. 2025. PMID: 39798194 Free article.
Correction: Estimation of Transition Probabilities from a Large Cohort (> 6000) of Australians Living with Multiple Sclerosis (MS) for Changing Disability Severity Classifications, MS Phenotype, and Disease-Modifying Therapy Classifications.
Campbell JA, Henson GJ, Ngwa VF, Ahmad H, Taylor BV, van der Mei I; MSBase Australian Researchers; Palmer AJ. Campbell JA, et al. Pharmacoeconomics. 2024 Dec 30. doi: 10.1007/s40273-024-01461-0. Online ahead of print. Pharmacoeconomics. 2024. PMID: 39739244 No abstract available.
493 results